New findings, published in the scientific journal, Breastfeeding Medicine show that new mothers who receive the drug ergotmetrine are more likely to experience pain or problems while breastfeeding as compared to their peers who are not administered the drug. Ergotmetrine is given to mothers to help speed up the delivery of the placenta, and it’s also used to control excessive bleeding following childbirth. However, the downside of this drug, given via injection, is that women who receive it are more likely to have problems breastfeeding, and are also significantly less likely to continue breastfeeding at all by the two and six week mark. While the injection had no significance when it came to moms choosing to breastfeed, many women who did get the injection stopped breastfeeding early on and pointed to physical pain while breastfeeding as a main reason. What this study suggests is that injections of ergotmetrine may not reduce breastfeeding initiation, but may seriously reduce duration. The researchers note that more research is needed to establish whether or not the pros of ergotmetrine outweigh the cons and that moms who need the drug to help control post-childbirth bleeding may also need extra breastfeeding support.